Related Experiment Video
Updated: Nov 2, 2025
10:00
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
13.6K
Interferon-alpha position in combating with COVID-19: A systematic review.
Ailar Nakhlband1, Ali Fakhari1, Hosein Azizi1,2
1Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Journal of Medical Virology
|June 8, 2021
Summary
Interferon alfa (IFN-α) treatment, combined with standard care, shows promise for treating COVID-19. This approach may accelerate viral clearance and reduce hospitalization duration in patients.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- The COVID-19 pandemic necessitated urgent exploration of effective treatments.
- Type I interferons (IFN-I), including IFN-α, are known for their antiviral properties.
- IFN-α emerged as a potential therapeutic agent for COVID-19.
Purpose of the Study:
- To systematically review the efficacy of IFN-α as a COVID-19 treatment.
- To compare patient outcomes with standard care versus standard care plus IFN-α.
Main Methods:
- A systematic literature search was conducted on PubMed, SCOPUS, and EMBASE up to October 1, 2020.
- Five studies were included after screening 356 identified records.
- Primary outcome: hospital discharge; Secondary outcome: virus clearance.
Main Results:
- Patients receiving IFN-α plus standard care showed decreased time to viral clearance.
- Mean days for virus clearance were 27.3 in the IFN-α group versus 32.43 in the standard care group.
- Average hospitalization duration was lower in the IFN-α group (18.55 days vs. 24.36 days).
Conclusions:
- Early administration of IFN-α may be a promising treatment strategy for COVID-19.
- IFN-α treatment appears to expedite viral clearance and shorten hospital stays.
- Further research into IFN-α for COVID-19 is warranted.
Related Concept Videos
01:29Immune Response Against Viral Pathogens
1.2K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.2K
01:23Antimicrobial Proteins
11.5K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
11.5K
01:22Methods of reducing fever
926
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
926
01:23RNA Interference
26.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.9K
01:13Controls in Experiments
14.3K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
14.3K
01:28Antimicrobial Effectiveness
672
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
672